Sodium chloride compound mixture
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Sodium bicarbonate + Sodium chloride
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(5)
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
Acute kidney injury: prevention, detection and management (NG148)
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography (HTG594)
The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney disease (MIB12)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 13 · Randomised trials: 18 · 1963–2026
Showing the 50 most relevant studies, sorted by most relevant.
Gregory J. Merten, W. Burgess, Lee V. Gray, et al.
JAMA, 2004
M. Haase, A. Haase-Fielitz, R. Bellomo, et al.
Critical Care Medicine, 2009
Somjot S. Brar, S. Hiremath, G. Dangas, et al.
Clinical journal of the American Society of Nephrology : CJASN, 2009
Jae-Sik Jang, Han-Young Jin, J. Seo, et al.
Circulation journal : official journal of the Japanese Circulation Society, 2012
Inokuchi R, Maeda A, Komaru Y, et al.
2026
- Alkalosis
- Hypernatremia
- Sodium Bicarbonate
BackgroundSodium bicarbonate is a common household compound often promoted for unproven health benefits. However, excessive ingestion can result in severe toxicity. This report describes a case of life-threatening metabolic alkalosis and hypernatremia following self-medication and presents a systematic review of sodium bicarbonate toxicity.Case reportA previously healthy man in his 30s presented with nausea and progressive weakness after ingesting 60 g of sodium bicarbonate daily for 2 months, escalating to 480 g immediately before admission for intestinal cleansing. Laboratory evaluation demonstrated severe metabolic alkalosis (pH 7.54; HCO₃- 54.5 mmol/L), hypernatremia (serum sodium 162 mEq/L), and chloride-resistant alkalosis. Supportive therapy, including oral acetazolamide, resulted in rapid biochemical normalization and complete clinical recovery.ReviewOur systematic review of 78 cases of sodium bicarbonate toxicity identified a shift in reported indications from dyspepsia to diverse uses, including pica, drug test avoidance, and natural remedies. Clinical presentations differed by ingestion pattern: acute, massive ingestion was often complicated by gastric rupture and was associated with high mortality, whereas chronic ingestion predominantly caused severe metabolic alkalosis and electrolyte abnormalities.ConclusionExcessive sodium bicarbonate ingestion can cause life-threatening complications. Clinicians should be alert to the risks of misuse driven by widely circulating unproven health claims.
Abstract licence: CC BY-NC-ND
V. Kunadian, A. Zaman, I. Spyridopoulos, et al.
European journal of radiology, 2011
S. Weisbord, M. Gallagher, H. Jneid, et al.
The New England Journal of Medicine, 2017
F. Rector
The American journal of physiology, 1983
Jeremiah R. Brown, Daniel M. Pearlman, E. Marshall, et al.
The American journal of cardiology, 2016
E. Adolph, Birgit Holdt-Lehmann, T. Chatterjee, et al.
Coronary Artery Disease, 2008
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Structured knowledge from the free knowledge base
Molecular structure

Linked open data from Wikidata (Q2314), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication. Molecular structure images from Wikimedia Commons. WHO INN from the World Health Organization.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.